Global Flu Vaccine Market Growth 2021-2026

  • receipt Report ID : 240525
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 136
  • list Pharmaceuticals and Healthcare

According to this latest study, the 2021 growth of Flu Vaccine will have significant change from previous year. By the most conservative estimates of global Flu Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 5042.3 million in 2020. Over the next five years the Flu Vaccine market will register a 5.0% CAGR in terms of revenue, the global market size will reach US$ 6124.1 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Flu Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

Trivalent Influenza Vaccine

Quadrivalent Influenza Vaccine

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

For Children (6 months to 3 years)

For Adults and Children over 3 years

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

Sanofi Pasteur

CSL

GSK

Mylan

Hulan Bio

AstraZeneca

CCBIO

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Flu Vaccine Consumption 2016-2026

2.1.2 Flu Vaccine Consumption CAGR by Region

2.2 Flu Vaccine Segment by Type

2.2.1 Trivalent Influenza Vaccine

2.2.2 Quadrivalent Influenza Vaccine

2.3 Flu Vaccine Sales by Type

2.3.1 Global Flu Vaccine Sales Market Share by Type (2016-2021)

2.3.2 Global Flu Vaccine Revenue and Market Share by Type (2016-2021)

2.3.3 Global Flu Vaccine Sale Price by Type (2016-2021)

2.4 Flu Vaccine Segment by Application

2.4.1 For Children (6 months to 3 years)

2.4.2 For Adults and Children over 3 years

2.5 Flu Vaccine Sales by Application

2.5.1 Global Flu Vaccine Sale Market Share by Application (2016-2021)

2.5.2 Global Flu Vaccine Revenue and Market Share by Application (2016-2021)

2.5.3 Global Flu Vaccine Sale Price by Application (2016-2021)

3 Global Flu Vaccine by Company

3.1 Global Flu Vaccine Sales Market Share by Company

3.1.1 Global Flu Vaccine Sales by Company (2019-2021)

3.1.2 Global Flu Vaccine Sales Market Share by Company (2019-2021)

3.2 Global Flu Vaccine Revenue Market Share by Company

3.2.1 Global Flu Vaccine Revenue by Company (2019-2021)

3.2.2 Global Flu Vaccine Revenue Market Share by Company (2019-2021)

3.3 Global Flu Vaccine Sale Price by Company

3.4 Global Manufacturers Flu Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Flu Vaccine Product Location Distribution

3.4.2 Players Flu Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Flu Vaccine by Region

4.1 Global Flu Vaccine by Region

4.1.1 Global Flu Vaccine Sales by Region

4.1.2 Global Flu Vaccine Revenue by Region

4.2 Americas Flu Vaccine Sales Growth

4.3 APAC Flu Vaccine Sales Growth

4.4 Europe Flu Vaccine Sales Growth

4.5 Middle East & Africa Flu Vaccine Sales Growth

5 Americas

5.1 Americas Flu Vaccine Sales by Country

5.1.1 Americas Flu Vaccine Sales by Country (2016-2021)

5.1.2 Americas Flu Vaccine Revenue by Country (2016-2021)

5.2 Americas Flu Vaccine Sales by Type

5.3 Americas Flu Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Flu Vaccine Sales by Region

6.1.1 APAC Flu Vaccine Sales by Region (2016-2021)

6.1.2 APAC Flu Vaccine Revenue by Region (2016-2021)

6.2 APAC Flu Vaccine Sales by Type

6.3 APAC Flu Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Flu Vaccine by Country

7.1.1 Europe Flu Vaccine Sales by Country (2016-2021)

7.1.2 Europe Flu Vaccine Revenue by Country (2016-2021)

7.2 Europe Flu Vaccine Sales by Type

7.3 Europe Flu Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Flu Vaccine by Country

8.1.1 Middle East & Africa Flu Vaccine Sales by Country (2016-2021)

8.1.2 Middle East & Africa Flu Vaccine Revenue by Country (2016-2021)

8.2 Middle East & Africa Flu Vaccine Sales by Type

8.3 Middle East & Africa Flu Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Flu Vaccine Distributors

10.3 Flu Vaccine Customer

11 Global Flu Vaccine Market Forecast

11.1 Global Flu Vaccine Forecast by Region

11.1.1 Global Flu Vaccine Forecast by Regions (2021-2026)

11.2.2 Global Flu Vaccine Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Flu Vaccine Forecast by Type

11.7 Global Flu Vaccine Forecast by Application

12 Key Players Analysis

12.1 Sanofi Pasteur

12.1.1 Sanofi Pasteur Company Information

12.1.2 Sanofi Pasteur Flu Vaccine Product Offered

12.1.3 Sanofi Pasteur Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Sanofi Pasteur Main Business Overview

12.1.5 Sanofi Pasteur Latest Developments

12.2 CSL

12.2.1 CSL Company Information

12.2.2 CSL Flu Vaccine Product Offered

12.2.3 CSL Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 CSL Main Business Overview

12.2.5 CSL Latest Developments

12.3 GSK

12.3.1 GSK Company Information

12.3.2 GSK Flu Vaccine Product Offered

12.3.3 GSK Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 GSK Main Business Overview

12.3.5 GSK Latest Developments

12.4 Mylan

12.4.1 Mylan Company Information

12.4.2 Mylan Flu Vaccine Product Offered

12.4.3 Mylan Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Mylan Main Business Overview

12.4.5 Mylan Latest Developments

12.5 Hulan Bio

12.5.1 Hulan Bio Company Information

12.5.2 Hulan Bio Flu Vaccine Product Offered

12.5.3 Hulan Bio Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Hulan Bio Main Business Overview

12.5.5 Hulan Bio Latest Developments

12.6 AstraZeneca

12.6.1 AstraZeneca Company Information

12.6.2 AstraZeneca Flu Vaccine Product Offered

12.6.3 AstraZeneca Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 AstraZeneca Main Business Overview

12.6.5 AstraZeneca Latest Developments

12.7 CCBIO

12.7.1 CCBIO Company Information

12.7.2 CCBIO Flu Vaccine Product Offered

12.7.3 CCBIO Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 CCBIO Main Business Overview

12.7.5 CCBIO Latest Developments

...

13 Research Findings and Conclusion

List of Tables

Table 1. Flu Vaccine Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Trivalent Influenza Vaccine

Table 3. Major Players of Quadrivalent Influenza Vaccine

Table 4. Global Flu Vaccine Sales by Type (2016-2021) & (M Doses)

Table 5. Global Flu Vaccine Sales Market Share by Type (2016-2021)

Table 6. Global Flu Vaccine Revenue by Type (2016-2021) & ($ million)

Table 7. Global Flu Vaccine Revenue Market Share by Type (2016-2021)

Table 8. Global Flu Vaccine Sale Price by Type (2016-2021)

Table 9. Global Flu Vaccine Sales by Application (2016-2021) & (M Doses)

Table 10. Global Flu Vaccine Sales Market Share by Application (2016-2021)

Table 11. Global Flu Vaccine Value by Application (2016-2021)

Table 12. Global Flu Vaccine Revenue Market Share by Application (2016-2021)

Table 13. Global Flu Vaccine Sale Price by Application (2016-2021)

Table 14. Global Flu Vaccine Sales by Company (2019-2021) & (M Doses)

Table 15. Global Flu Vaccine Sales Market Share by Company (2019-2021)

Table 16. Global Flu Vaccine Revenue by Company (2019-2021) ($ Millions)

Table 17. Global Flu Vaccine Revenue Market Share by Company (2019-2021)

Table 18. Global Flu Vaccine Sale Price by Company (2019-2021)

Table 19. Key Manufacturers Flu Vaccine Producing Area Distribution and Sales Area

Table 20. Players Flu Vaccine Products Offered

Table 21. Flu Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 22. New Products and Potential Entrants

Table 23. Mergers & Acquisitions, Expansion

Table 24. Global Flu Vaccine Sales by Region (2016-2021) (M Doses)

Table 25. Global Flu Vaccine Sales Market Share by Region (2016-2021)

Table 26. Global Flu Vaccine Revenue by Region (2016-2021) & ($ Millions)

Table 27. Global Flu Vaccine Revenue Market Share by Region (2016-2021)

Table 28. Americas Flu Vaccine Sales by Country (2016-2021) & (M Doses)

Table 29. Americas Flu Vaccine Sales Market Share by Country (2016-2021)

Table 30. Americas Flu Vaccine Revenue by Country (2016-2021) & ($ Millions)

Table 31. Americas Flu Vaccine Revenue Market Share by Country (2016-2021)

Table 32. Americas Flu Vaccine Sales by Type (2016-2021) & (M Doses)

Table 33. Americas Flu Vaccine Sales Market Share by Type (2016-2021)

Table 34. Americas Flu Vaccine Sales by Application (2016-2021) & (M Doses)

Table 35. Americas Flu Vaccine Sales Market Share by Application (2016-2021)

Table 36. APAC Flu Vaccine Sales by Region (2016-2021) & (M Doses)

Table 37. APAC Flu Vaccine Sales Market Share by Region (2016-2021)

Table 38. APAC Flu Vaccine Revenue by Region (2016-2021) & ($ Millions)

Table 39. APAC Flu Vaccine Revenue Market Share by Region (2016-2021)

Table 40. APAC Flu Vaccine Sales by Type (2016-2021) & (M Doses)

Table 41. APAC Flu Vaccine Sales Market Share by Type (2016-2021)

Table 42. APAC Flu Vaccine Sales by Application (2016-2021) & (M Doses)

Table 43. APAC Flu Vaccine Sales Market Share by Application (2016-2021)

Table 44. Europe Flu Vaccine Sales by Country (2016-2021) & (M Doses)

Table 45. Europe Flu Vaccine Sales Market Share by Country (2016-2021)

Table 46. Europe Flu Vaccine Revenue by Country (2016-2021) & ($ Millions)

Table 47. Europe Flu Vaccine Revenue Market Share by Country (2016-2021)

Table 48. Europe Flu Vaccine Sales by Type (2016-2021) & (M Doses)

Table 49. Europe Flu Vaccine Sales Market Share by Type (2016-2021)

Table 50. Europe Flu Vaccine Sales by Application (2016-2021) & (M Doses)

Table 51. Europe Flu Vaccine Sales Market Share by Application (2016-2021)

Table 52. Middle East & Africa Flu Vaccine Sales by Country (2016-2021) & (M Doses)

Table 53. Middle East & Africa Flu Vaccine Sales Market Share by Country (2016-2021)

Table 54. Middle East & Africa Flu Vaccine Revenue by Country (2016-2021) & ($ Millions)

Table 55. Middle East & Africa Flu Vaccine Revenue Market Share by Country (2016-2021)

Table 56. Middle East & Africa Flu Vaccine Sales by Type (2016-2021) & (M Doses)

Table 57. Middle East & Africa Flu Vaccine Sales Market Share by Type (2016-2021)

Table 58. Middle East & Africa Flu Vaccine Sales by Application (2016-2021) & (M Doses)

Table 59. Middle East & Africa Flu Vaccine Sales Market Share by Application (2016-2021)

Table 60. Key and Potential Regions of Flu Vaccine

Table 61. Key Application and Potential Industries of Flu Vaccine

Table 62. Key Challenges of Flu Vaccine

Table 63. Key Trends of Flu Vaccine

Table 64. Flu Vaccine Distributors List

Table 65. Flu Vaccine Customer List

Table 66. Global Flu Vaccine Sales Forecast by Region (2021-2026) & (M Doses)

Table 67. Global Flu Vaccine Consumption Market Forecast by Region

Table 68. Global Flu Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)

Table 69. Global Flu Vaccine Revenue Market Share Forecast by Region (2021-2026)

Table 70. Americas Flu Vaccine Sales Forecast by Country (2021-2026) & (M Doses)

Table 71. Americas Flu Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)

Table 72. APAC Flu Vaccine Sales Forecast by Region (2021-2026) & (M Doses)

Table 73. APAC Flu Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)

Table 74. Europe Flu Vaccine Sales Forecast by Country (2021-2026) & (M Doses)

Table 75. Europe Flu Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)

Table 76. Middle East & Africa Flu Vaccine Sales Forecast by Country (2021-2026) & (M Doses)

Table 77. Middle East & Africa Flu Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)

Table 78. Global Flu Vaccine Sales Forecast by Type (2021-2026) & (M Doses)

Table 79. Global Flu Vaccine Sales Market Share Forecast by Type (2021-2026)

Table 80. Global Flu Vaccine Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 81. Global Flu Vaccine Revenue Market Share Forecast by Type (2021-2026)

Table 82. Global Flu Vaccine Sales Forecast by Application (2021-2026) & (M Doses)

Table 83. Global Flu Vaccine Sales Market Share Forecast by Application (2021-2026)

Table 84. Global Flu Vaccine Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 85. Global Flu Vaccine Revenue Market Share Forecast by Application (2021-2026)

Table 86. Sanofi Pasteur Basic Information, Flu Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 87. Sanofi Pasteur Flu Vaccine Product Offered

Table 88. Sanofi Pasteur Flu Vaccine Sales (M Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 89. Sanofi Pasteur Main Business

Table 90. Sanofi Pasteur Latest Developments

Table 91. CSL Basic Information, Flu Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 92. CSL Flu Vaccine Product Offered

Table 93. CSL Flu Vaccine Sales (M Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 94. CSL Main Business

Table 95. CSL Latest Developments

Table 96. GSK Basic Information, Flu Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 97. GSK Flu Vaccine Product Offered

Table 98. GSK Flu Vaccine Sales (M Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 99. GSK Main Business

Table 100. GSK Latest Developments

Table 101. Mylan Basic Information, Flu Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 102. Mylan Flu Vaccine Product Offered

Table 103. Mylan Flu Vaccine Sales (M Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 104. Mylan Main Business

Table 105. Mylan Latest Developments

Table 106. Hulan Bio Basic Information, Flu Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 107. Hulan Bio Flu Vaccine Product Offered

Table 108. Hulan Bio Flu Vaccine Sales (M Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 109. Hulan Bio Main Business

Table 110. Hulan Bio Latest Developments

Table 111. AstraZeneca Basic Information, Flu Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 112. AstraZeneca Flu Vaccine Product Offered

Table 113. AstraZeneca Flu Vaccine Sales (M Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 114. AstraZeneca Main Business

Table 115. AstraZeneca Latest Developments

Table 116. CCBIO Basic Information, Flu Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 117. CCBIO Flu Vaccine Product Offered

Table 118. CCBIO Flu Vaccine Sales (M Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 119. CCBIO Main Business

Table 120. CCBIO Latest Developments

List of Figures

Figure 1. Picture of Flu Vaccine

Figure 2. Flu Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Flu Vaccine Sales Growth Rate 2016-2026 (M Doses)

Figure 7. Global Flu Vaccine Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Flu Vaccine Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Trivalent Influenza Vaccine

Figure 10. Product Picture of Quadrivalent Influenza Vaccine

Figure 11. Global Flu Vaccine Sales Market Share by Type in 2020

Figure 12. Global Flu Vaccine Revenue Market Share by Type (2016-2021)

Figure 13. Flu Vaccine Consumed in For Children (6 months to 3 years)

Figure 14. Global Flu Vaccine Market: For Children (6 months to 3 years) (2016-2021) & (M Doses)

Figure 15. Flu Vaccine Consumed in For Adults and Children over 3 years

Figure 16. Global Flu Vaccine Market: For Adults and Children over 3 years (2016-2021) & (M Doses)

Figure 17. Global Flu Vaccine Sales Market Share by Application (2016-2021)

Figure 18. Global Flu Vaccine Revenue Market Share by Application in 2020

Figure 19. Flu Vaccine Revenue Market by Company in 2020 ($ Million)

Figure 20. Global Flu Vaccine Revenue Market Share by Company in 2020

Figure 21. Global Flu Vaccine Sales Market Share by Regions (2016-2021)

Figure 22. Global Flu Vaccine Revenue Market Share by Region in 2020

Figure 23. Americas Flu Vaccine Sales 2016-2021 (M Doses)

Figure 24. Americas Flu Vaccine Revenue 2016-2021 ($ Millions)

Figure 25. APAC Flu Vaccine Sales 2016-2021 (M Doses)

Figure 26. APAC Flu Vaccine Revenue 2016-2021 ($ Millions)

Figure 27. Europe Flu Vaccine Sales 2016-2021 (M Doses)

Figure 28. Europe Flu Vaccine Revenue 2016-2021 ($ Millions)

Figure 29. Middle East & Africa Flu Vaccine Sales 2016-2021 (M Doses)

Figure 30. Middle East & Africa Flu Vaccine Revenue 2016-2021 ($ Millions)

Figure 31. Americas Flu Vaccine Sales Market Share by Country in 2020

Figure 32. Americas Flu Vaccine Revenue Market Share by Country in 2020

Figure 33. Americas Flu Vaccine Sales Market Share by Type in 2020

Figure 34. Americas Flu Vaccine Sales Market Share by Application in 2020

Figure 35. United States Flu Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 36. Canada Flu Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 37. Mexico Flu Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 38. Brazil Flu Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 39. APAC Flu Vaccine Sales Market Share by Region in 2020

Figure 40. APAC Flu Vaccine Revenue Market Share by Regions in 2020

Figure 41. APAC Flu Vaccine Sales Market Share by Type in 2020

Figure 42. APAC Flu Vaccine Sales Market Share by Application in 2020

Figure 43. China Flu Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 44. Japan Flu Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 45. Korea Flu Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 46. Southeast Asia Flu Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 47. India Flu Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 48. Australia Flu Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 49. Europe Flu Vaccine Sales Market Share by Country in 2020

Figure 50. Europe Flu Vaccine Revenue Market Share by Country in 2020

Figure 51. Europe Flu Vaccine Sales Market Share by Type in 2020

Figure 52. Europe Flu Vaccine Sales Market Share by Application in 2020

Figure 53. Germany Flu Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 54. France Flu Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 55. UK Flu Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 56. Italy Flu Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 57. Russia Flu Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 58. Middle East & Africa Flu Vaccine Sales Market Share by Country in 2020

Figure 59. Middle East & Africa Flu Vaccine Revenue Market Share by Country in 2020

Figure 60. Middle East & Africa Flu Vaccine Sales Market Share by Type in 2020

Figure 61. Middle East & Africa Flu Vaccine Sales Market Share by Application in 2020

Figure 62. Egypt Flu Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 63. South Africa Flu Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 64. Israel Flu Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 65. Turkey Flu Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 66. GCC Country Flu Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery